Ducluzeau R, Ladire M, Callut C, Raibaud P, Abrams G D
Infect Immun. 1977 Aug;17(2):415-24. doi: 10.1128/iai.17.2.415-424.1977.
Two extremely oxygen-sensitive strains of Clostridium sp., designated Clostridium E and P, were obtained from digestive microflora of conventional mice and found to constitute a barrier against Shigella flexneri SF-2 when associated in vivo with Escherichia coli K-12. These and other simplified fractions of the conventional microflora were demonstrated to have an effect comparable to that of the total flora. When K-12 and Clostridium E were established in gnotobiotic mice before the introduction of SF-2, the latter was reduced to a level below detection in the digestive tract. Whe SF-2 was established first, the antagonistic effect exerted by Clostridium E and K-12 was variable and, apparently, related to the rate of establishment of Clostridium E. Mutants of SF-2 resistant to the barrier effect of Clostridium E and K-12 appeared at the end of 3 months when SF-2 was established in gnotobiotic mice alone or with K-12, and after only a week when SF-2 was associated only with Clostridium E. These results suggest that the bacterial antagonsim in this model is related to the production in vivo of an antibiotic substance active against SF-2. It appears that the substance may be produced by Clostridium E, stimulated by K-12.
从常规小鼠的消化微生物区系中获得了两种对氧气极度敏感的梭菌菌株,分别命名为梭菌E和梭菌P。研究发现,当它们在体内与大肠杆菌K-12联合时,可构成针对福氏志贺菌SF-2的一道屏障。已证明这些以及常规微生物区系的其他简化部分具有与整个微生物区系相当的作用。当在无菌小鼠中先定殖K-12和梭菌E,再引入SF-2时,后者在消化道中的数量降至检测水平以下。若先定殖SF-2,则梭菌E和K-12发挥的拮抗作用不定,且显然与梭菌E的定殖速度有关。当单独在无菌小鼠中或与K-12一起定殖SF-2时,3个月末出现了对梭菌E和K-12的屏障作用具有抗性的SF-2突变体;而当SF-2仅与梭菌E联合时,仅在一周后就出现了这种突变体。这些结果表明,该模型中的细菌拮抗作用与体内产生的一种对SF-2有活性的抗生素物质有关。看来该物质可能由梭菌E产生,并受到K-12的刺激。